Implications of key trials in advanced nonsmall cell lung cancer-Reference-Cited by-同舟云学术

Implications of key trials in advanced nonsmall cell lung cancer

Published:2010-03-01 Issue:5 Volume:116 Page:1155-1164
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bonomi Philip D.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24815/fullpdf

Reference60 articles.

1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008

2. Randomized phase 3 trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial;Kelly;J Clin Oncol,2001

3. Comparison of 4 chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

4. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease;Delbaldo;Cochrane Database Syst Rev,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Rationale for a Phase II, Randomized, Open-Label, Two-Cohort Multicenter Interventional Study of Osimertinib with or Without Savolitinib in De Novo MET Aberrant, EGFR-Mutant Patients with Advanced Non-Small-Cell Lung Cancer: The FLOWERS Trial;Clinical Lung Cancer;2023-01

2. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma;BMC Cancer;2020-11-03

3. Clinical case of long-term use of atezolizumab and bevacizumab in the first-line treatment of recurrence of non-small cell lung cancer;Meditsinskiy sovet = Medical Council;2020-07-30

4. Real-world use of osimertinib in non–small cell lung cancer: ASTRIS study Korean subgroup analysis;Current Medical Research and Opinion;2020-01-19

5. A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancer;Journal of Cerebral Blood Flow & Metabolism;2019-04-20